Works about TACROLIMUS

Results: 4134
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Single-center, retrospective analysis of efficacy and safety of tacrolimus as a second-line DMARD in combination therapy and the risk factors contributing to adverse events in 115 patients with rheumatoid arthritis.

    Published in:
    Clinical Rheumatology, 2012, v. 31, n. 2, p. 251, doi. 10.1007/s10067-011-1810-6
    By:
    • Ogasawara, Michihiro;
    • Tamura, Naoto;
    • Kageyama, Michiaki;
    • Onuma, Shin;
    • Kusaoi, Makio;
    • Toyama, Shoko;
    • Sekiya, Fumio;
    • Matsudaira, Ran;
    • Nawata, Masuyuki;
    • Tada, Kurisu;
    • Matsushita, Masakazu;
    • Kempe, Kazuo;
    • Amano, Hirofumi;
    • Morimoto, Shinji;
    • Yamaji, Ken;
    • Takasaki, Yoshinari
    Publication type:
    Article
    26
    27
    28
    29
    30
    31

    Has widespread use of biologic and immunosuppressant therapy for ulcerative colitis affected surgical trends? Results of a questionnaire survey of surgical institutions in Japan.

    Published in:
    Surgery Today, 2016, v. 46, n. 8, p. 930, doi. 10.1007/s00595-015-1259-3
    By:
    • Kimura, Hideaki;
    • Takahashi, Kenichi;
    • Futami, Kitaro;
    • Ikeuchi, Hiroki;
    • Tatsumi, Kenji;
    • Watanabe, Kazuhiro;
    • Maeda, Kiyoshi;
    • Watadani, Yusuke;
    • Nezu, Riichiro;
    • Kameyama, Hitoshi;
    • Nakao, Sayumi;
    • Kurachi, Kiyotaka;
    • Hotokezaka, Masayuki;
    • Otsuka, Koki;
    • Watanabe, Toshiaki;
    • Ozawa, Heita
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50